NA
MYOK

Neuburgh Advisers’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Neuburgh Advisers’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$22K Hold
416
– – ﹤0.01% 886
2019
Q2 		$21K Hold
416
– – ﹤0.01% 887
2019
Q1 		$22K Buy
416
+96
+30% +$4.42K ﹤0.01% 885
2018
Q4 		$16K Buy
+320
New +$17.6K ﹤0.01% 869

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Neuburgh Advisers's MYOK Position: Q3 2019 in Review

Neuburgh Advisers held its MyoKardia, Inc. Common Stock (MYOK) position steady in Q3 2019 at 416 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

Neuburgh Advisers first reported a position in MYOK in Q4 2018 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

  • Neuburgh Advisers held 416 shares of MyoKardia, Inc. Common Stock worth $22K as of Q3 2019.
  • Neuburgh Advisers left its MyoKardia, Inc. Common Stock share count unchanged in Q3 2019.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #886 holding.
  • Neuburgh Advisers first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.